tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (SE:ELIC)
:ELIC
Sweden Market

Elicera Therapeutics AB (ELIC) Cash flow

Compare
1 Followers

Elicera Therapeutics AB Cash Flow

SE:ELIC's free cash flow for Q4 2024 was kr-4.23M. For the 2024 fiscal year, SE:ELIC's free cash flow was decreased by kr-8.54M and operating cash flow was kr-4.23M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -905.25K
Investing Cash Flow
kr 0.00kr 483.17Kkr 0.00kr -1.00Kkr -8.88K
Financing Cash Flow
kr 20.48Mkr 0.00kr 0.00kr 55.12Mkr 12.45M
End Cash Position
kr 26.40Mkr 29.38Mkr 43.82Mkr 52.39Mkr 11.56M
Free Cash Flow
kr -23.46Mkr -14.92Mkr -8.57Mkr -14.29Mkr -964.13K
Currency in SEK

Elicera Therapeutics AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis